CD199 (CCR9) Antibody, anti-human, APC-Vio® 770, REAfinity™, 30 tests in 60 µL
文献支持

CD199 (CCR9) Antibody, anti-hu

man, APC-Vio® 770, REAfinity™, 30 tests in 60 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-134-786
  • 2025年12月09日
  • Flow cytometry, Mass cytometry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      CD199 (CCR9)

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REA469

    • 标记物

      APC-Vio 770

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Flow cytometry, Mass cytometry

    • 浓度

      1:50

    • 抗体英文名

      CD199 (CCR9) Antibody, anti-human, REAfinity™

    • 抗体名

      CD199 (CCR9) Antibody, anti-human, REAfinity™

    • 规格

      30 tests in 60 µL

    Identification and enumeration of CD199+ cells by flow cytometryClone REA469 recognizes the human CD199 antigen, a multi-pass membrane protein which is also known as C-C chemokine receptor type 9 (CCR9) or G-protein coupled receptor 28 (GPR28). CD199 is a receptor for the chemokine thymus-expressed chemokine (TECK) and a member of the G protein coupled receptor family (GPCR). The main function of GPCR family members is to send signals into the cell after the activation of G-proteins and they are known for their roles in inflammation, leukocyte trafficking, and immune differentiation. CD199 subsequently transduces a signal by increasing the intracellular calcium ions level. It influences T cell development at several stages within the thymus. In peripheral blood, CD199 is expressed by naive CD8+ T cells, but not by naive CD4+ T cells. It is furthermore selectively expressed on plasmacytoid dendritic cells of immature phenotype in vivo. Different studies have shown the involvement of the CD199-TECK axis in colorectal, prostate, ovarian, and breast cancers. | Additional information: Clone REA469 displays negligible binding to Fc receptors.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Zaballos, A. et al. (1999) Cutting Edge: Identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol 162 (10): 5671–5675. | Hadeiba, H. et al. (2008) CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 9: 1253–1260. | Zhang, Z. et al. (2014) CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma. Oncol. Rep. 31 (4): 1629–1636.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月15日询价
    ¥2095
    北京达科为生物技术有限公司
    2025年07月14日询价
    ¥1698
    苏州奕赛生物科技有限公司
    2025年07月09日询价
    询价
    普健生物(武汉)科技有限公司
    2025年07月16日询价
    文献支持
    CD199 (CCR9) Antibody, anti-human, APC-Vio® 770, REAfinity™, 30 tests in 60 µL
    询价